Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells

E. Giovannetti, M. Labots, H. Dekker, E. Galvani, J.S.W. Lind, R. Sciarrillo, R.J. Honeywell, E.F. Smit, H.M. Verheul, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)927-939
JournalCurrent Pharmaceutical Design
Volume19
Issue number5
DOIs
Publication statusPublished - 2013

Cite this